Tech Company Financing Transactions
Vascular Magnetics Funding Round
On 2/23/2012, Vascular Magnetics raised $7 million in Series A financing from Devon Park Bioventures.
Transaction Overview
Company Name
Announced On
2/23/2012
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Devon Park Bioventures (Christopher Moller)
Proceeds Purpose
The funds will allow us to complete the preclinical development of the system and conduct an initial clinical trial.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
3711 Market Street 8th Floor
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
Vascular Magnetics, Inc. is magnetically targeting drug-loaded biodegradable particles to develop Vascular Magnetic Intervention (VMI), a novel therapy for peripheral artery disease (PAD). PAD is a common chronic condition characterized by obstruction (stenosis) of the arteries in the legs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Georges Gemayel
Chief Financial Officer
Joel Sussman
Chief Operating Officer
Richard Woodward
Chief Scientific Officer
Robert Levy
Browse more venture capital transactions:
Prev: 2/23/2012: Centice venture capital transaction
Next: 2/23/2012: SimpleReach venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs